Pivotal Study of Voro Urologic Scaffold
NCT: NCT06873581 · RECRUITING
Brief Summary
The objective of this study is to compare safety and effectiveness of the Voro Urologic Scaffold in adult men undergoing robotic assisted radical prostatectomy as compared to control arm. The study is a multi-center, single blind, randomized, controlled trial. Up to 266 participants will be treated at up to 30 centers in the United States. The study will consist of a Baseline visit, implantation during robotic assisted radical prostatectomy (RARP), catheter removal, 6 weeks, 6 months, 12 months, 18 months, and 24 months.
Frequently Asked Questions
What is Pivotal Study of Voro Urologic Scaffold?
Pivotal Study of Voro Urologic Scaffold is a clinical trial registered under NCT06873581. Current status: RECRUITING.
What is the status of NCT06873581?
The current status of NCT06873581 (Pivotal Study of Voro Urologic Scaffold) is: RECRUITING.
When did Pivotal Study of Voro Urologic Scaffold start?
Pivotal Study of Voro Urologic Scaffold started on 2025-04-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.